Integrated Alcohol Use Disorder and Liver Disease Management
Seminars in Liver Disease · 2025-12 · 45 (04) · 517-530
DOI: 10.1055/a-2717-3496 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, online erschienen am 28.10.2025. Verfasst von Hanna Blaney und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medstar Transplant Hepatology Institute, MedStar Georgetown University Hospital, Washington, District of Columbia. Hauptthemen laut MEDLINE: Liver Diseases, Alcoholic, Delivery of Health Care, Integrated, Alcoholism. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 133 Literaturangaben.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Alcohol-associated liver disease (ALD) is a leading cause of liver disease worldwide, caused by hazardous alcohol use. Many patients with ALD also have alcohol use disorder (AUD), a chronic mental health condition characterized by a cluster of behavioral, cognitive, and physiological symptoms that indicate continued alcohol use despite significant alcohol-related problems. Comprehensive care of ALD often requires treatment of AUD, and evidence has demonstrated that treating the latter improves patient outcomes. However, only a minority of patients with AUD/ALD receive treatment. Integrative care models where hepatologists work alongside AUD specialists have been developed. These partnerships have been associated with improved outcomes, including decreased rates of return to alcohol use, decreased healthcare utilization, and even improved mortality. We review the epidemiology, diagnosis, and treatment of AUD and ALD, examples of successful integrated care models, and outcomes. We also discuss knowledge gaps and areas where future research is needed, including the role of integrated care in the peri-transplantation period for ALD, harm reduction approaches, and the need for efforts to support collaboration for integrative care. In conclusion, the dual pathologies of AUD and ALD necessitate multidisciplinary care, and integrated care models have been shown to be both feasible and effective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Medstar Transplant Hepatology Institute, MedStar Georgetown University Hospital, Washington, District of Columbia.
- Department of Hepatology, Paris-Est Créteil University, Hôpital Henri-Mondor, Assistance Publique Hôpitaux de Paris, Paris, France.
- Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan.
- Department of Psychiatry and Behavioral Medicine, Henry Ford Health, Detroit, Michigan.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan.
- Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia.
ORCID-Profile: Hanna Blaney, Adelina Horhat, Jessica Mellinger, Juan P Arab
Zitieren
APA
Blaney, H., Horhat, A., Saleem, A., Winder, G. S., Mellinger, J., & Arab, J. P. (2025). Integrated Alcohol Use Disorder and Liver Disease Management. Seminars in Liver Disease, 45(04), 517-530. https://doi.org/10.1055/a-2717-3496
Vancouver
Blaney H, Horhat A, Saleem A, Winder GS, Mellinger J, Arab JP. Integrated Alcohol Use Disorder and Liver Disease Management. Seminars in Liver Disease. 2025;45(04):517-530. doi:10.1055/a-2717-3496
BibTeX
@article{Blaney2025,
author = {Blaney, Hanna and Horhat, Adelina and Saleem, Abdulmalik and Winder, Gerald S and Mellinger, Jessica and Arab, Juan P},
title = {Integrated Alcohol Use Disorder and Liver Disease Management},
journal = {Seminars in Liver Disease},
year = {2025},
volume = {45},
number = {04},
pages = {517--530},
doi = {10.1055/a-2717-3496}
}
EUVIMED